SUPPLEMENT PROTOCOL - AN OVERVIEW

below both equally Drake’s and Lynch’s designs, the expense of deleterious mutations is exactly what drives mutation premiums down (Drake 1991; Lynch 2010; Sung et al. 2012). for that reason, below both designs, an increase in the average cost of mutations would lead to a lower in mutation costs. to look at this, Drake examined mutation fees of